MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

488382

Report Date :

31.01.2018

 

IDENTIFICATION DETAILS

 

Name :

BIOCAD INDIA PRIVATE LIMITED

 

 

Registered Office :

No.163/C, 3rd Cross, 3rd Phase, J.P. Nagar, Bangalore – 560078, Karnataka

Mobile No.:

91-9740163609 (Mr. Karthikeyan S)

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

30.03.2012

 

 

Com. Reg. No.:

08- 063319

 

 

Capital Investment / Paid-up Capital :

INR 0.100 Million

 

 

CIN No.:

[Company Identification No.]

U74900KA2012PTC063319

 

 

IEC No.:

Not Divulged

 

 

GSTIN/UIN:

29AAECB9542M1Z3

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAECB9542M

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

  • The company provides services in pharmaceutical research i.e conduction of clinical trials, preparation of dossier and procurement of active pharmaceutical ingredients. [Registered activity]

 

  • Manufacturing of biotechnological and pharmaceutical products dedicated to treat complex health conditions such as cancer, HIV and Hepatitis C Infections, multiple sclerosis and other disorders. [Confirmed by management]

 

 

No. of Employees :

60 (Approximately)

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A

 

Credit Rating

Explanation

Rating Comments

A

Acceptable Risk

Business dealings permissible with moderate risk of default

 

Maximum Credit Limit :

USD 30000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated in the year 2012 having satisfactory track record. It is engaged as manufacturer of bio technological and pharmaceutical products dedicated to treat complex health conditions such as cancer, HIV and Hepatitis C infections, multiple sclerosis and other disorders.

 

For the financial year 2017, the company has achieved top line growth in its revenue as compared to its previous year along with fair profit margin during the year.

 

Rating takes into consideration, the satisfactory financial risk profile marked by adequate net worth base and strong debt protection metric.

 

Rating continue to derive strength from its established record of its business operation backed by its strong financial support from its holding entity.

 

However, these rating strengths are partially offset by exposure to intense completion in the international generics market, and growing regulatory scrutiny in emerging market, along with growing competition, substantial investment in infrastructure and R&D which impact in  profitability pressure among the major players.

 

Payments seems to be slow but correct.

 

In view of aforesaid, the company can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.06.2017)

Current Rating

(30.09.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 31.01.2018

 

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

INFORMATION PARTED BY

 

Name :

Mr. Karthikeyan S

Designation :

Project Manager

Contact No.:

91-9740163609

Date :

30.01.2018

 

 

LOCATIONS

 

Registered Office / factory:

No.163/C, 3rd Cross, 3rd Phase, J.P. Nagar, Bangalore – 560078, Karnataka, India

Tel. No.:

91-80-41699773

Mobile No.:

91-9740163609 (Mr. Karthikeyan S)

91-9035538824 (Mr. Raghu)

Fax No.:

Not Available

E-Mail :

karthikeyans@biocadindia.com

krishnamurthy.rao@biocadindia.com

Website :

https://biocadglobal.com

 

 

Head Office :

Located at

 

  • Russia

 

 

DIRECTORS

 

AS ON 31.03.2017

 

Name :

Mr. Chinnabhandara Anantrao Krishnamurthyrao

Designation :

Managing Director

Address :

1219, 26th Main, 9th Block, Jayanagara, Bangalore – 560069, Karnataka, India

Date of Birth/Age :

08.12.1971

Date of Appointment :

01.07.2017

DIN No.:

06588194

 

 

Name :

Mr. Roman Alekseyevich Ivanov

Designation :

Director

Address :

Planetnaya Street 29/2-176, Moscow Russia 125167

Date of Birth/Age :

02.08.1977

Date of Appointment :

30.03.2012

DIN No.:

05209351

 

 

KEY EXECUTIVES

 

Name :

Mr. Karthikeyan S

Designation :

Project Manager

 

 

MAJOR SHAREHOLDERS

 

AS ON 31.03.2017

 

Names of Shareholders

No. of Shares

% of Holding

CJSC Biocad

900

90.00

Biocad Pharma LLC

100

10.00

Total

1000

100.00

 

 

Equity Share Break up (Percentage of Total Equity)

 

AS ON 30.10.2017

 

Category

Percentage

Promoters- Body corporate

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

  • The company provides services in pharmaceutical research i.e conduction of clinical trials, preparation of dossier and procurement of active pharmaceutical ingredients. [Registered activity]

 

  • Manufacturing of biotechnological and pharmaceutical products dedicated to treat complex health conditions such as cancer, HIV and Hepatitis C Infections, multiple sclerosis and other disorders. [Confirmed by management]

 

 

Products / Services :

Name and Description of main products / services

NIC Code of the Product/service

The company provides services in pharmaceutical research i.e conduction of clinical trials, preparation of dossier and procurement of active pharmaceutical ingredients.

--

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged 

 

 

Imports :

 

Products :

Raw material

Countries :

Russia

 

 

Terms :

 

Selling :

Cheque and Others (RTGS)

 

 

Purchasing :

Cheque and Others (RTGS)

 

 

PRODUCTION STATUS – (NOT AVAILABLE)

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

Customers :

End Users, OEM’s

 

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

No. of Employees :

60 (Approximately)

 

 

Bankers :

Banker Name :

Kotak Mahindra Bank

Branch :

Bangalore, Karnataka, India

Person Name (With Designation) :

--

Contact Number :

--

Name of Account Holder :

--

Account Number :

--

Account Since (Date/Year of Account Opening) :

--

Average Balance Maintained :

--

Credit Facilities Enjoyed (CC/OD/Term Loan) :

--

Account Operation :

--

Remark :

--

 

 

Auditors :

 

Name :

Raghavendra Naik and Associates

Chartered Accountants

Address :

51, Stock Exchange Towers (Annexe), 1st Cross, J C Road, Bangalore- 560027, Karnataka, India

PAN N Income-tax PAN of auditor or auditor's firm :

AAPFR9433F

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Parent Company :

  • CJSC Biocad (Russia)

 

CAPITAL STRUCTURE

 

AS ON 31.03.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1000

Equity Shares

INR 100/- each

INR 0.100 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1000

Equity Shares

INR 100/- each

INR 0.100 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are INR Million]

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2017

31.03.2016

31.03.2015

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

0.100

0.100

0.100

(b) Reserves & Surplus

10.465

6.812

6.097

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

10.565

6.912

6.197

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

0.000

0.000

0.000

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

1.670

0.000

0.000

(b) Trade payables

7.355

0.220

18.279

(c) Other current liabilities

3.825

4.355

84.375

(d) Short-term provisions

16.201

5.254

3.439

Total Current Liabilities (4)

29.051

9.829

106.093

 

 

 

 

TOTAL

39.616

16.741

112.290

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

1.259

1.008

1.562

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.367

0.142

0.055

(d)  Long-term Loan and Advances

0.900

0.800

0.800

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

2.526

1.950

2.417

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

1.427

5.776

1.564

(c) Trade receivables

25.885

0.000

0.000

(d) Cash and cash equivalents

4.449

4.825

8.127

(e) Short-term loans and advances

4.460

3.423

21.594

(f) Other current assets

0.869

0.767

78.588

Total Current Assets

37.090

14.791

109.873

 

 

 

 

TOTAL

39.616

16.741

112.290

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

Income

83.597

36.178

68.489

 

Other Income

0.037

0.266

0.548

 

TOTAL

83.634

36.444

69.037

 

 

(Increase in order)

 

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

2.519

3.375

15.168

 

Employees benefits expense

17.317

14.684

12.195

 

Operating Expenses

46.227

5.235

26.622

 

Other expenses

11.783

11.460

11.232

 

TOTAL

77.846

34.754

65.217

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

5.788

1.690

3.820

 

 

 

 

 

Less

FINANCIAL EXPENSES

0.000

0.000

0.000

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

5.788

1.690

3.820

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

0.286

0.591

1.370

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

5.502

1.099

2.450

 

 

 

 

 

Less

TAX

1.849

0.384

0.916

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

3.653

0.715

1.534

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

3652.73

715.01

1533.80

 

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

NA

NA

NA

 

 

 

 

Cash generated from operations

(0.946)

(2.527)

(12.412)

 

 

 

 

Net cash flows from (used in) operations

(1.446)

(3.528)

(14.069)

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365 Days)

113.02

0.00

0.00

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

3.23

0.00

0.00

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

1065.73

23.79

439.86

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

4.06

0.29

2.44

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

4.60

1.68

2.45

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.73

0.59

0.94

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.16

0.00

0.00

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

2.75

1.42

17.12

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.12

0.15

0.25

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

0.00

0.00

0.00

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Net Profit Margin

((PAT / Sales) * 100)

%

4.37

1.98

2.24

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

9.22

4.27

1.37

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

34.58

10.34

24.75

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Current Ratio

(Current Assets / Current Liabilities)

1.28

1.50

1.04

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

1.23

0.92

1.02

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.27

0.41

0.06

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

16.70

0.00

0.00

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

1.28

1.50

1.04

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

FINANCIAL ANALYSIS

[all figures are INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Share Capital

0.100

0.100

0.100

Reserves & Surplus

6.097

6.812

10.465

Share Application money pending allotment

0.000

0.000

0.000

Net worth

6.197

6.912

10.565

 

 

 

 

Long Term borrowings

0.000

0.000

0.000

Short Term borrowings

0.000

0.000

1.670

Total borrowings

0.000

0.000

1.670

Debt/Equity ratio

0.000

0.000

0.158

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

68.489

36.178

83.597

 

 

(47.177)

131.071

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

68.489

36.178

83.597

Profit

1.534

0.715

3.653

 

2.24%

1.98%

4.37%

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

Yes

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

No

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

Yes

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

INDEX OF CHARGE: No Charges Exists for Company

 

BACKGROUND

 

Subject has been incorporated on 30th March, 2012 under companies Act, 1956. The company provides services in pharmaceutical research i.e conduction of clinical trials, preparation of dossier and procurement of active pharmaceutical ingredients.

 

UNSECURED LOANS:

 

(INR In Million)

Particulars

As on

31.03.2017

As on

31.03.2016

SHORT TERM BORROWING

 

 

Loan from directors

1.670

0.000

Total

1.670

0.000

 

FIXED ASSETS:

 

  • Furniture and fittings
  • Office Equipment’s
  • Plant and Machinery
  • Motor Vehicles
  • Computers and Laptops
  • Services and Networks

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 63.75

UK Pound

1

INR 89.39

Euro

1

INR 78.75

 

 

INFORMATION DETAILS

 

Information Gathered by :

SUP

 

 

Analysis Done by :

NIS

 

 

Report Prepared by :

KVT

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.